Mitochondrial targeting domain of NOXA causes necrosis in apoptosis-resistant tumor cells

Dai-Trang Nguyen1, Siyuan He1, Ji-Hye Han1

  • 1Department of Biochemistry and Molecular Biology, Chosun University School of Medicine, Rm # 2219, Medical Building # 2, 309 Pilmoon-Daero, Dong-Gu, Gwang-Ju, 61452, Republic of Korea.

Amino Acids
|September 10, 2018
PubMed

Insights

A novel necrosis-inducing peptide effectively kills apoptosis-resistant tumor cells. This peptide, R8:MTD, offers a potential new strategy for treating cancers that resist conventional chemotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor cell resistance to apoptosis-inducing agents is a significant challenge in cancer therapy.
  • Developing alternative therapeutic strategies is crucial for overcoming treatment resistance.

Purpose of the Study:

  • To investigate the efficacy of a necrosis-inducing peptide containing a mitochondria-targeting domain (MTD) against apoptosis-resistant tumor cells.
  • To evaluate the potential of R8:MTD as a novel anticancer agent for resistant cancers.

Main Methods:

  • Established doxorubicin-resistant (Dox-Res) CT26 cells.
  • Confirmed apoptosis resistance in Dox-Res cells via cell viability and caspase activation assays.
  • Administered R8:MTD peptide and assessed tumor cell necrosis, cytosolic calcium spikes, reactive oxygen species (ROS) production, and high mobility group box 1 (HMGB1) release.
  • Evaluated R8:MTD efficacy in a mouse model using Dox-Res CT26 tumor xenografts.

Main Results:

  • R8:MTD induced necrosis in Dox-Res CT26 cells.
  • Necrosis was accompanied by cytosolic calcium influx, ROS generation, and HMGB1 release.
  • R8:MTD demonstrated significant tumor-killing effects in vivo within a mouse model of resistant tumors.

Conclusions:

  • MTD-containing peptides, such as R8:MTD, can effectively eliminate tumor cells resistant to apoptosis-inducing therapies.
  • These peptides represent a promising alternative therapeutic approach for relapsed or refractory cancers.
  • Further research into MTD-containing peptides could lead to new treatments for challenging cancer types.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.6K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.1K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.3K
Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.6K
Export of Mitochondrial and Chloroplast Genes02:19

Export of Mitochondrial and Chloroplast Genes

A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred...
4.2K
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
16.3K